Levetiracetam Sandoz

Levetiracetam, the active ingredient in Levetiracetam Sandoz, is an anticonvulsant presented as an oral tablet for oral use. It is employed to manage various seizure types in patients with epilepsy, including partial, generalized tonic‑clonic, and myoclonic seizures, and is prescribed by neurologists as part of individualized therapy.

GNH USA supplies Levetiracetam Sandoz as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide and procurement teams in both public and private health sectors, ensuring consistent quality and regulatory compliance across regions.

Levetiracetam is an antiepileptic medication used to control seizure activity in epilepsy. - Partial seizures: Reduces frequency of focal onset seizures in patients with epilepsy. - Generalized tonic‑clonic seizures: Decreases occurrence of bilateral convulsive seizures. - Myoclonic seizures: Controls brief, shock‑like muscle jerks associated with certain epilepsy syndromes. - Adjunct therapy for Lennox‑Gastaut syndrome: Helps lower seizure burden when combined with other agents.

Levetiracetam may cause a range of adverse reactions, varying in frequency and severity.

Common Side Effects: - Dizziness: Sensation of light‑headedness or unsteadiness. - Somnolence: Increased sleepiness or fatigue. - Irritability: Mood changes including agitation. - Headache: Mild to moderate cranial pain.

Serious or Rare Side Effects: - Severe allergic reaction: Including rash, swelling, or anaphylaxis. - Stevens‑Johnson syndrome: Rare skin disorder with blistering. - Suicidal thoughts or behavior: Emergence of depressive symptoms or self‑harm ideation.

When prescribing levetiracetam, several safety considerations should be observed. - Dose adjustment in renal impairment: Reduce dose according to creatinine clearance. - Monitor for behavioral changes: Observe patients for irritability or mood swings. - Avoid abrupt discontinuation: Taper under medical supervision to prevent seizure worsening. - Pregnancy and lactation: Use only if benefit outweighs risk; data limited. - Drug interactions: Review concomitant medications for potential interactions. - Store at ambient temperature: Keep below 25°C in original container, protect from moisture.

Levetiracetam can interact with other medicines, requiring attention to avoid reduced efficacy or increased toxicity.

Major Interactions (Avoid): - Concomitant use with carbamazepine: May reduce levetiracetam plasma levels. - Co‑administration with enzyme‑inducing antiepileptics (phenytoin, phenobarbital): May decrease efficacy. - Strong inhibitors of renal tubular secretion (e.g., probenecid): May increase levetiracetam levels.

Moderate Interactions (Monitor Closely): - Combination with other CNS depressants (benzodiazepines, alcohol): May enhance sedation. - Use with antidepressants (SSRIs): Potential for increased behavioral side effects. - Concurrent use with immunosuppressants (e.g., tacrolimus): Monitor drug levels.